Latest News

Macular Degeneration Research

The FDA has approved a new dosing regimen for Eylea, an injectable drug to treat degenerative eye diseases such as wet age-related macular degeneration. This means people taking the drug may need these eye injections less frequently. 

Aug 28, 2023
BrightFocus Foundation

Global brain and vision research nonprofit BrightFocus Foundation has appointed three industry leaders to its board of directors.

Aug 21, 2023
Macular Degeneration Research

Izervay, a second drug to treat the advanced and severe form of dry macular degeneration known as geographic atrophy, has received full FDA approval, opening another avenue of hope for people with this vision-stealing condition.

Aug 8, 2023
National Glaucoma Research

Harnessing the power of artificial intelligence, researchers have identified nearly 200 previously unknown DNA regions linked to a risk of developing glaucoma, findings that could lead to new ways of preventing the disease. 

Aug 3, 2023
Alzheimer's Disease Research

A BrightFocus-funded team has identified a potential way to diagnose a rare but devastating form of early Alzheimer’s disease by examining cells of the inner eye.

Aug 3, 2023
Alzheimer's Disease Research

Global nonprofit BrightFocus Foundation is pleased to announce that it has received a $50,000 donation from Alzheimer’s Los Angeles (Alzheimer’s LA) to support two innovative Alzheimer’s disease research scientists as part of the Foundation’s 2023 research portfolio.

Aug 1, 2023